{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:36:42Z","timestamp":1793939802179,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","award":["26176"],"award-info":[{"award-number":["26176"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ibneur.2023.03.004","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T21:03:49Z","timestamp":1678223029000},"page":"285-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Salivary levels of disease-related biomarkers in the early stages of Parkinson\u2019s and Alzheimer\u2019s disease: A cross-sectional study"],"prefix":"10.1016","volume":"14","author":[{"given":"Masoomeh","family":"Sabaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Rahimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsh","family":"Haj Mohamad Ebrahim Ketabforoush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homa","family":"Rasoolijazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahime","family":"Hajiakhoundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoureh","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3889-4973","authenticated-orcid":false,"given":"Gholamali","family":"Shahidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Faramarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ibneur.2023.03.004_bib1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4103\/1947-2714.147980","article-title":"Saliva \u03b1-synuclein and a high extinction coefficient protein: a novel approach in assessment biomarkers of Parkinson's disease","volume":"6","author":"Al-Nimer","year":"2014","journal-title":"North Am. J. Med. Sci."},{"key":"10.1016\/j.ibneur.2023.03.004_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.parkreldis.2017.05.023","article-title":"Factor structure of the montreal cognitive assessment items in a sample with early Parkinson's disease","volume":"41","author":"Benge","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ibneur.2023.03.004_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-10-108","article-title":"Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study","volume":"10","author":"Bermejo-Pareja","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ibneur.2023.03.004_bib4","doi-asserted-by":"crossref","first-page":"33691","DOI":"10.1074\/jbc.M112.379792","article-title":"Novel one-step immunoassays to quantify \u03b1-synuclein: applications for biomarker development and high-throughput screening","volume":"287","author":"Bidinosti","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ibneur.2023.03.004_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000351864","article-title":"Evidence of the sensitivity of the MoCA alternate forms in monitoring cognitive change in early Alzheimer's disease","volume":"37","author":"Costa","year":"2014","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.ibneur.2023.03.004_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awr015","article-title":"Salivary \u03b1-synuclein and DJ-1: potential biomarkers for Parkinson's disease","volume":"134","author":"Devic","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ibneur.2023.03.004_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.31887\/DCNS.2009.11.2\/bdubois","article-title":"Early detection of Alzheimer's disease: new diagnostic criteria","volume":"11","author":"Dubois","year":"2009","journal-title":"Dialog-. Clin. Neurosci."},{"key":"10.1016\/j.ibneur.2023.03.004_bib8","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society\u2010sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS\u2010UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.ibneur.2023.03.004_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036581","article-title":"High LRRK2 levels fail to induce or exacerbate neuronal alpha-synucleinopathy in mouse brain","volume":"7","author":"Herzig","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ibneur.2023.03.004_bib10","series-title":"Neuropathology simplified: a guide for clinicians and neuroscientists","author":"Hilton","year":"2015"},{"key":"10.1016\/j.ibneur.2023.03.004_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-01820-6","article-title":"The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer\u2019s disease: a longitudinal PET study","volume":"17","author":"Ismail","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.ibneur.2023.03.004_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fnagi.2014.00102","article-title":"Salivary DJ-1 could be an indicator of Parkinson's disease progression","volume":"6","author":"Kang","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ibneur.2023.03.004_bib13","first-page":"616a","article-title":"Antibody-based magnetic nanoparticle immunoassay for quantification of salivary beta-amyloid peptides","volume":"106","author":"Kim","year":"2014","journal-title":"Biophys. J."},{"key":"10.1016\/j.ibneur.2023.03.004_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/ijms17020189","article-title":"Molecular pathological classification of neurodegenerative diseases: turning towards precision medicine","volume":"17","author":"Kovacs","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ibneur.2023.03.004_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0197-4580(98)00012-8","article-title":"Biochemical diagnostic markers to detect early Alzheimer\u2019s disease","volume":"19","author":"Lannfelt","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ibneur.2023.03.004_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0299-y","article-title":"Diagnosis of Alzheimer\u2019s disease utilizing amyloid and tau as fluid biomarkers","volume":"51","author":"Lee","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ibneur.2023.03.004_bib17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3233\/JAD-160748","article-title":"A method for diagnosing Alzheimer\u2019s disease based on salivary amyloid-\u03b2 protein 42 levels","volume":"55","author":"Lee","year":"2017","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.ibneur.2023.03.004_bib18","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","article-title":"Parkinson's disease: from monogenic forms to genetic susceptibility factors","volume":"18","author":"Lesage","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ibneur.2023.03.004_bib19","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1056\/NEJMcp0910236","article-title":"Early Alzheimer's disease","volume":"362","author":"Mayeux","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ibneur.2023.03.004_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Mckhann","year":"2011","journal-title":"Alzheimer'S. Dement."},{"key":"10.1016\/j.ibneur.2023.03.004_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fneur.2019.00391","article-title":"Beta amyloid deposition is not associated with cognitive impairment in Parkinson's disease","volume":"10","author":"Melzer","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ibneur.2023.03.004_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jalz.2016.09.014","article-title":"Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic","volume":"13","author":"O'bryant","year":"2017","journal-title":"Alzheimer'S. Dement."},{"key":"10.1016\/j.ibneur.2023.03.004_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/odi.13201","article-title":"Can oral health and oral\u2010derived biospecimens predict progression of dementia?","volume":"26","author":"Orr","year":"2020","journal-title":"Oral. Dis."},{"key":"10.1016\/j.ibneur.2023.03.004_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/diagnostics11020371","article-title":"The role of salivary biomarkers in the early diagnosis of Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"11","author":"Pawlik","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.ibneur.2023.03.004_bib25","first-page":"53","article-title":"Development and validation of a salivary tau biomarker in Alzheimer's disease. Alzheimer's & Dementia: Diagnosis","volume":"11","author":"Pekeles","year":"2019","journal-title":"Assess. Dis. Monit."},{"key":"10.1016\/j.ibneur.2023.03.004_bib26","doi-asserted-by":"crossref","first-page":"10.1. 1","DOI":"10.1002\/0471142301.ns1001s49","article-title":"Assessment of Parkinson disease manifestations","volume":"49","author":"Perlmutter","year":"2009","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.ibneur.2023.03.004_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","article-title":"Non\u2010motor symptoms in Parkinson\u2019s disease","volume":"15","author":"Poewe","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ibneur.2023.03.004_bib28","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ibneur.2023.03.004_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2020.108980","article-title":"A novel approach to correlate the salivary exosomes and their protein cargo in the progression of cognitive impairment into Alzheimer\u2019s disease","volume":"347","author":"Rani","year":"2021","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ibneur.2023.03.004_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-8-20","article-title":"Fluid biomarkers in Alzheimer\u2019s disease\u2013current concepts","volume":"8","author":"Ros\u00e9n","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ibneur.2023.03.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-018-1160-y","article-title":"Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer\u2019s disease dementia from normal controls: preliminary findings","volume":"18","author":"Sabbagh","year":"2018","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ibneur.2023.03.004_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41983-020-0159-7","article-title":"Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson\u2019s disease","volume":"56","author":"Shaheen","year":"2020","journal-title":"Egypt. J. Neurol. Psychiatry Neurosurg."},{"key":"10.1016\/j.ibneur.2023.03.004_bib33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/JAD-2011-110731","article-title":"Salivary tau species are potential biomarkers of Alzheimer's disease","volume":"27","author":"Shi","year":"2011","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.ibneur.2023.03.004_bib34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.neurobiolaging.2013.08.008","article-title":"Cheek cell\u2013derived \u03b1-synuclein and DJ-1 do not differentiate Parkinson's disease from control","volume":"35","author":"Stewart","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ibneur.2023.03.004_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151156","article-title":"Abnormal salivary total and oligomeric alpha-synuclein in Parkinson\u2019s disease","volume":"11","author":"Vivacqua","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.ibneur.2023.03.004_bib36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jamaneurol.2017.3713","article-title":"Associations between tau, \u03b2-amyloid, and cognition in Parkinson disease","volume":"75","author":"Winer","year":"2018","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.ibneur.2023.03.004_bib37","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3390\/biomedicines10071702","article-title":"Systematic review on saliva biomarkers in patients diagnosed with morbus Alzheimer and Morbus Parkinson","volume":"2022","author":"Wolgin","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ibneur.2023.03.004_bib38","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1212\/01.wnl.0000230160.13272.1b","article-title":"Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease","volume":"67","author":"Zhu","year":"2006","journal-title":"Neurology"}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242123000210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242123000210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:13:16Z","timestamp":1757405596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242123000210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":38,"alternative-id":["S2667242123000210"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2023.03.004","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salivary levels of disease-related biomarkers in the early stages of Parkinson\u2019s and Alzheimer\u2019s disease: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2023.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}